Home > Insider Trading > Filing (0001209191-19-034560)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1278710	Robert Coffman	C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-06-02	54,702	$0.00	132,470	No	4	M	Direct
Common Stock	Disposition	2019-06-04	22,484	$4.58	109,986	No	4	F	Direct
Common Stock	Disposition	2019-06-04	32,218	$4.58	77,768	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock unit	Disposition	2019-06-02	54,702	$0.00	54,702	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over two years with 50% vesting on each annual anniversary of June 2, 2017.
The reporting person is reporting the withholding by Dynavax Technologies Corporation of 22,484 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on June 2, 2019.